BrainsWay (BWAY) vs Carlsmed (CARL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BrainsWay (BWAY) has outperformed Carlsmed (CARL) over the past year, gaining 47.8% versus a gain of 5.8%. BrainsWay is the larger company by market cap ($461.7 million vs $383.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BWAY | CARL |
|---|---|---|
| Share price | $11.47 | $14.05 |
| Market cap | $461.70M | $383.60M |
| 1-day change | -1.29% | -2.29% |
| YTD return | +20.61% | +16.44% |
| 1-year return | +47.76% | +5.81% |
| 5-year return | +197.57% | — |
| P/E ratio (TTM) | 49.87 | — |
| Forward P/E | 22.64 | — |
| EPS (TTM) | $0.23 | $-1.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.40 | $17.23 |
| 52-week low | $7.14 | $8.50 |
| Distance from 52-week high | -34.08% | -18.46% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +68.00% | +36.65% |
| Average volume | 119.71K | 125.43K |
| Shares outstanding | 40.25M | 27.30M |
| Employees | 129 | 127 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BWAY has outperformed CARL by 41.9 percentage points over the past year.
About BrainsWay
BWAY stock →BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 129 employees
About Carlsmed
CARL stock →Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.
Health Care · Medical/Dental Instruments · 127 employees
BWAY vs CARL FAQ
Which is bigger, BrainsWay or Carlsmed?
BrainsWay (BWAY) is larger, with a market capitalization of $461.70M compared with $383.60M for Carlsmed (CARL).
Which stock has performed better over the past year, BWAY or CARL?
BWAY returned +47.76% over the past 12 months, compared with +5.81% for CARL (price return, excluding dividends). Past performance does not predict future results.
Are BrainsWay and Carlsmed in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.